Environmental Factor – August 2019: Society of Toxicologic Pathology looks to One Health

Organizers of the Society of Toxicologic Pathology’s (STP) annual meeting set their sights on environmental factors involved in disease. A particular focus was on One Health,

READ MORE

Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/ß-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

TOKYO, Japan & MALVERN, Pa., United States:   —Expected to Be First Commercially-Available Blood-Based In-Vitro Diagnostic for Patients Being Assessed for

READ MORE